IMNM Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Immunome Inc

Watchlist Manager

Watchlist

Price: 19.75 USD 2.17% Market Closed

Market Cap: $2.2B

	Immunome Inc NASDAQ:IMNM	US
J	JPMorgan Chase & Co SGO:JPM	US
A	Autodesk Inc XHAM:AUD	US
W	WW Grainger Inc XMUN:GWW	US

Profitability Summary

Immunome Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-3 085%

Negative 3Y Average Operating Margin

-1 183%

Declining Operating Margin

-1 259% > -3 085%

Negative Net Margin

-3 060%

Negative 3Y Average Net Margin

-1 893%

Declining Net Margin

-1 277% > -3 060%

Negative Free Cash Flow Margin

-2 980%

Negative 3Y Average Free Cash Flow Margin

-1 184%

Declining Free Cash Flow Margin

64% > -2 980%

Negative ROE

-52%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-7 825%

ROIC is Increasing

-4 436% > -1 219%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.